OCS Heart
DevicePreservation of donor hearts with OCS Heart System and novel OCS Solution and OCS Functional Enhancer.
NCT Number: NCT07145515
This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
University of California San Francisco, San Francisco, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Part A - DCD Donor Hearts & DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage (Current Approved Indications):
Donor Inclusion Criteria
Donor Exclusion • Moderate to severe aortic incompetence
Part B - DBD Donor Hearts Currently Used with Cold Storage (New Indication):
Donor Inclusion Criteria
Donor Exclusion
Recipient Eligibility Criteria (for Part A and B Cohorts)
Inclusion
Exclusion
Preservation of donor hearts with OCS Heart System and novel OCS Solution and OCS Functional Enhancer.
Preservation of donor hearts with static cold storage.
Time frame: 30-day post transplant
The primary endpoint is 30-day patient and graft survival with freedom from moderate or severe LV or RV primary graft dysfunction (PGD) in the first 24 hours post-transplant.
Contact information is provided by the study sponsor or research team.
Kausar Qidwai
CONTACT
Raicca Haqqi
CONTACT
TransMedics
Industry
Enhancing Heart Allograft Function With the OCS Heart System (ENHANCE) Trial
Acronym: ENHANCE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06478017
Heart Transplant
Los Angeles, California, United States
View Trial DetailsNCT06426173
Cardiovascular Diseases, Heart Diseases
São Paulo, Brazil
View Trial DetailsNCT04770012
Cardiac Allograft Vasculopathy, Heart Transplant
Vancouver, British Columbia, Canada
View Trial DetailsNCT06895070
Cardiovascular Diseases, Heart Diseases
La Jolla, California, United States
View Trial Details